Lukas Shumway
Stock Analyst at Barclays
(0.78)
# 4,100
Out of 5,043 analysts
18
Total ratings
47.1%
Success rate
-7.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lukas Shumway
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterated: Buy | $36 | $19.55 | +84.14% | 5 | Oct 1, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $56 | $14.27 | +292.43% | 4 | Oct 1, 2026 | |
| CLLS Cellectis | Downgraded: Sell | $9 → $1.3 | $1.26 | +3.17% | 3 | Sep 15, 2026 | |
| DRTS Alpha Tau Medical | Reiterated: Buy | $17 → $30 | $14.41 | +108.19% | 6 | Sep 2, 2026 |
Immunome
Oct 1, 2026
Reiterated: Buy
Price Target: $36
Current: $19.55
Upside: +84.14%
Sutro Biopharma
Oct 1, 2026
Reiterated: Buy
Price Target: $56
Current: $14.27
Upside: +292.43%
Cellectis
Sep 15, 2026
Downgraded: Sell
Price Target: $9 → $1.3
Current: $1.26
Upside: +3.17%
Alpha Tau Medical
Sep 2, 2026
Reiterated: Buy
Price Target: $17 → $30
Current: $14.41
Upside: +108.19%